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Abstract
Paralogs for several proteins implicated in neurodegenerative disorders have been identified and explored to further
facilitate the identification of molecular mechanisms contributing to disease pathogenesis. For the disease-causing protein
in spinocerebellar ataxia type 2, ataxin-2, a paralog of unknown function, termed ataxin-2-like, has been described. We
discovered that ataxin-2-like associates with known interaction partners of ataxin-2, the RNA helicase DDX6 and the poly(A)-
binding protein, and with ataxin-2 itself. Furthermore, we found that ataxin-2-like is a component of stress granules.
Interestingly, sole ataxin-2-like overexpression led to the induction of stress granules, while a reduction of stress granules
was detected in case of a low ataxin-2-like level. Finally, we observed that overexpression of ataxin-2-like as well as its
reduction has an impact on the presence of microscopically visible processing bodies. Thus, our results imply a functional
overlap between ataxin-2-like and ataxin-2, and further indicate a role for ataxin-2-like in the regulation of stress granules
and processing bodies.
Citation: Kaehler C, Isensee J, Nonhoff U, Terrey M, Hucho T, et al. (2012) Ataxin-2-Like Is a Regulator of Stress Granules and Processing Bodies. PLoS ONE 7(11):
e50134. doi:10.1371/journal.pone.0050134
Editor: Jiyan Ma, Ohio State University, United States of America
Received August 23, 2012; Accepted October 17, 2012; Published November 27, 2012
Copyright:  2012 Kaehler et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: krobitsc@molgen.mpg.de
¤ Current address: The Jackson Laboratory, Bar Harbor, Maine, United States of America
Introduction
Late-onset neurodegenerative disorders have been intensively
studied over the last two decades. However, the molecular
mechanisms responsible for their pathologies remain to be
elucidated. Of note, some knowledge was gained by exploring
the physiological function of paralogous proteins identified for
several disease proteins. Regarding the family of polyglutamine
disorders, which includes Huntington’s disease, spinobulbar
muscular atrophy, dentatorubral pallidoluysian atrophy, and
spinocerebellar ataxia (SCA) type 1, 2, 3, 6, 7 & 17 [1,2,3,4], a
gene duplication of ataxin-1-like (ATXN1L)/Brother of ataxin-1
(Boat), the respective paralog of the disease-causing protein ataxin-
1 (ATXN1), ameliorated the observed neurotoxicity in a SCA1
mouse model, indicating overlapping functionality between
paralog and disease protein [5].
The search for the gene causing SCA2 led to the isolation of the
SCA2 gene [6,7,8], which comprises an intrinsic CAG repeat that
is interrupted by 1–3 CAA triplets in healthy individuals, while a
continuous CAG repeat of more than 34 repeats has been
observed in affected individuals [6,8,9]. The expansion on the
genetic level is causal for an extended polyglutamine domain in the
SCA2 gene product ataxin-2 (ATXN2). Interestingly, these efforts
also resulted in the isolation of a partial cDNA sequence on
chromosome 16 that showed high homology to the SCA2 gene
sequence [7]. The encoded protein showed high homology with
ATXN2 and was therefore named ataxin-2-related protein (A2RP)
[10]. Independently from these studies, Meunier and colleagues
reported the identification of a gene at the same chromosome
locus and named the respective gene product ataxin-2 domain
protein (A2D) [11]. Proteins of the A2RP or A2D family, which we
refer to as ataxin-2-like (ATXN2L), are widely expressed in human
tissues and orthologs are present in other species [10]. Comparison
of the derived amino acid sequences of ATXN2 and ATXN2L
showed that several motifs are conserved such as the N-terminal
acidic domain containing the mRNA-binding motifs Sm1 and
Sm2, putative caspase-3 cleavage sites, a clathrin-mediated trans-
Golgi signal, and an endoplasmic reticulum exit signal. Further-
more, both proteins comprise the binding motif for the PABC
domain of the poly(A)-binding protein (PABP), termed PAM2
[10,12]. Despite these shared motifs, the polyglutamine tract is not
conserved between ATXN2 and ATXN2L [10].
Considering the high degree of structural similarity between
ATXN2 and ATXN2L, a functional overlap between these
paralogs is likely. Regarding the cellular function of ATXN2L,
which remains to be understood, an association with the
erythropoietin receptor has been reported suggesting a function
in cytokine signaling [11]. To this point, a role of ATXN2 in
endocytic processes and RNA-processing pathways was demon-
strated [13,14,15,16,17]. Concerning its function in the cellular
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RNA metabolism, ATXN2 is found in association with PABP,
further being a dosage-dependent regulator of this protein
[14,15]. Moreover, direct interactions of ATXN2 with RNA
splicing factors and RNA-binding proteins have been described
[18,19]. Finally, an association of ATXN2 with polyribosomes
and direct binding of ATXN2 to RNA was demonstrated [20],
and ATXN2 has been identified as a component of stress
granules (SGs) [14,15]. These are dynamic cellular structures
assembling in mammalian cells in response to diverse cellular
stresses representing sites of mRNA regulation. SGs contain
untranslated mRNAs, eukaryotic initiation factors, small ribo-
somal subunits, various RNA-binding proteins, and proteins
implicated in cell signaling [21,22,23]. Furthermore, there is a
dynamic interplay between SGs and processing bodies (P-
bodies), sites of mRNA degradation that comprise components
of microRNA or RNAi pathways as well as the nonsense-
mediated mRNA decay pathway [24].
In this study, we considered a potential functional overlap
between ATXN2L and ATXN2 with regard to RNA metabolism.
We discovered that ATXN2L associates with known ATXN2
interaction partners such as the RNA helicase DDX6 and PABP,
and with ATXN2 itself. Furthermore, we observed that ATXN2L
is a bona fide component of SGs. Finally, we report that ATXN2L
overexpression as well as its reduction has a regulatory effect on
SGs and P-bodies.
Results
ATXN2L Associates with PABP, DDX6, and ATXN2
Since ATXN2L and ATXN2 share most functional motifs and
domains as outlined in Fig. 1A [10], both proteins likely act in
related pathways. Our earlier work demonstrated that ATXN2
interacts with PABP and with the RNA helicase DDX6/Rck
[14,15]. In this regard, the PAM2 motif, a binding motif found in
proteins interacting with the PABC domain of PABP [12], is also
present in ATXN2L. Moreover, the acidic domain, which
comprises the LSm domain and the LSm-associated domain
(LSmAD), represents the interaction surface between ATXN2 and
DDX6, and is 69% identical (80% sequence similarity) in both
proteins [10,15,25]. Accordingly, we set out to analyze whether
ATXN2L is also found in association with PABP and DDX6. For
this, we performed co-immunoprecipitation experiments using cell
lysates prepared from HEK293T and HeLa cells. After incubation
of cell lysates with an antibody directed against ATXN2L,
precipitated proteins were analyzed by immunoblotting. As shown
in Fig. 1B, we were able to precipitate endogenous PABP (left
panel) and DDX6 (middle panel) with an ATXN2L-specific
antibody from both cell lysates. Due to this finding, we additionally
investigated whether ATXN2L and ATXN2 are found in
association as well. Again, cell lysates were prepared from these
two cell lines and processed as described. We observed that
endogenous ATXN2 was precipitated with the ATXN2L-specific
antibody as well (Fig. 1B, right panel). In addition, we included the
neuroblastoma cell line SH-SY5Y used previously [15] and
observed same results (Fig. S1A). Thus, ATXN2L is found in a
complex comprising PABP, DDX6, and ATXN2 in mammalian
cells indicating that ATXN2L is involved in cellular RNA
processing pathways as well.
Next we investigated the intracellular localization of endoge-
nous ATXN2L by confocal microscopy as described in Materials
and Methods. This analysis revealed that ATXN2L is primarily
cytoplasmic but also present in nuclear structures that co-localize
with SR proteins (Fig. 1C, upper panel). These represent markers
of nuclear splicing speckles [26], which belong to a family of
splicing regulators with a characteristic domain rich in arginine
and serine residues [27]. Thus, ATXN2L is a component of
splicing speckles. Since a nuclear localization was also reported for
ATXN2 [28], we further analyzed whether endogenous ATXN2
is part of these structures as well. As shown in Fig. 1C (lower
panel), nuclear ATXN2 did not co-localize with SR-positive
structures in HeLa cells under the chosen conditions. Thus, our
findings indicate that ATXN2L is associated with the nuclear
splicing machinery.
ATXN2L is a Component of SGs
Since ATXN2, DDX6, and PABP are known components of
SGs [14,15,29,30], we investigated in the next step whether
endogenous ATXN2L is part of these cellular structures as well.
To induce the formation of SGs, HeLa cells were first treated with
sodium arsenite or heat-shocked. Then, cells were fixed and
stained with ATXN2- and ATXN2L-specific antibodies, and the
localization of both proteins was analyzed by confocal microscopy.
As shown in Fig. 2A, ATXN2L localizes in distinct cytoplasmic
foci in arsenite- and heat-treated cells, which were also positive for
ATXN2. We also included the core SG marker proteins T-cell-
restricted intracellular antigen-1-related protein (TIAR) and PABP
in this analysis, and detected a co-localization of ATXN2L-
positive foci with TIAR- and PABP-positive foci in arsenite- and
heat-treated cells (Fig. S1B, S1C). Since the composition of SGs
can vary under different stress conditions [22,23,31], we investi-
gated the localization of ATXN2L under additional stresses, such
as osmotic stress induced by sorbitol [32], ER stress induced by
dithiothreitol (DTT) [33], and oxidative stress induced by sodium
selenite or hydrogen peroxide (H2O2) [34,35]. Also under these
conditions ATXN2L formed cytoplasmic foci that co-localize with
ATXN2-positive foci (Fig. 2B). Moreover, we performed stress
experiments in the presence of cycloheximide, a setting preventing
SG assembly [21]. For this, HeLa cells were treated with arsenite
in the presence of cycloheximide, fixed, and analyzed by confocal
microscopy. We observed that ATXN2L and ATXN2 retained
their cytoplasmic distribution in HeLa cells with concurrent
cycloheximide treatment, whereas in arsenite-treated control cells
both proteins are localized to SGs (Fig. 3A). We also performed
this experiment with heat-treated cells and made the same
observations (Fig. S2A). Finally, we analyzed the localization of
ATXN2L under conditions in which SGs disassemble [21].
Subsequent to arsenite treatment, HeLa cells were incubated for
additional 90–180 min under normal growth conditions, fixed,
and analyzed by confocal microscopy. As shown in Fig. 3B,
ATXN2L-positive as well as ATXN2-positive foci dispersed in
arsenite-treated cells after 180 min recovery and both proteins
were diffusely distributed throughout the cytoplasm. Again, similar
findings were obtained under heat stress (Fig. S2B). In conclusion,
our results demonstrate that ATXN2L is a bona fide SG
component.
Altered Intracellular ATXN2L Concentration Influences SG
Formation
A high-throughput approach revealed an association between
ATXN2L and the RasGAP-associated endoribonuclease G3BP
[36], which if overexpressed induces the formation of SGs per se
[37]. Accordingly, we first confirmed the described association
between ATXN2L and G3BP. For this, co-immunoprecipitation
experiments were carried out with HEK293T and HeLa cell
lysates. As shown in Fig. 4A, we were able to precipitate
endogenous G3BP with an ATXN2L-specific antibody (left panel),
and endogenous ATXN2L with a G3BP-specific antibody (right
panel). Moreover, we investigated whether ATXN2 is also
ATXN2L Regulates Stress Granules and P-Bodies
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associated with G3BP and carried out further co-immunoprecip-
itation experiments. We observed that endogenous G3BP was
precipitated with an antibody directed against ATXN2 and vice
versa (Fig. 4B), demonstrating complex formation between both
ataxin proteins and G3BP.
Next we addressed the question whether ATXN2L overex-
pression may possibly induce SGs as the SG marker protein
G3BP does [37]. We transfected HeLa cells with the respective
plasmids for overexpressing ATXN2L, ATXN2, or G3BP, and
analyzed their impact on SG induction using the SG marker
protein eukaryotic translation initiation factor 4 gamma (eIF4G)
in our confocal microscopy analysis. Of note, we observed that
cells with ATXN2L overexpression exhibited eIF4G-positive
foci, while eIF4G remained evenly distributed in non-transfected
cells (Fig. 4C, upper panel). SG formation was not detected in
ATXN2 overexpressing cells using eIF4G staining (Fig. 4C,
middle panel). As expected, we observed that overexpressed
G3BP co-localized with eIF4G-positive foci (Fig. 4C, lower
panel). Thus, overexpression of ATXN2L induces SG forma-
tion.
In this regard, we showed earlier that reduction of the
intracellular ATXN2 level has an impact on SG formation [15].
Consequently, we analyzed the influence of a reduced ATXN2L
level on SG formation as well. First we verified the ATXN2L or
ATXN2 knock down by immunoblotting and microscopy (Fig.
S3). Then, we transfected HeLa cells with specific siRNA
molecules targeting ATXN2L or ATXN2 transcripts, with
unspecific non-targeting (NT) siRNA molecules, or left cells
untreated (mock), and exposed cells to arsenite stress 72 h after
transfection. After fixation the SG marker proteins eIF4G and
TIAR were stained and analyzed by confocal microscopy. As
shown in Fig. 5A, cells with reduced ATXN2L or ATXN2 level
exhibited fewer and smaller eIF4G-positive foci compared to
control cells (mock and siNT). To further corroborate and quantify
these findings, we additionally performed an automated micros-
copy approach based on a Cellomics ArrayScan VTI high-content
screening platform. This system automatically acquires images of
stained cells in multi-well plates. Cells are identified by nuclear
staining and fixed object selection parameters, and SGs are
quantified within a circular area extending the nuclear region (Fig.
S4; for details please see Materials and Methods). First, we
excluded that transfection of siRNA molecules has an impact on
cell survival or the nuclear size representing a basic morphological
parameter (Fig. 5B). Of note, we observed that in cells with a
lowered ATXN2L level the number of eIF4G- and TIAR-positive
SGs was significantly reduced to 3464% or 4665% compared to
the non-targeting control (p,0.001, n = 5 replicate wells/condi-
tion, 6 SD) (Fig. 5C and S4). As expected, cells with a reduced
ATXN2 level also exhibited fewer eIF4G- and TIAR-positive SGs
(Fig. 5C and S4). In addition, the size of SGs was considerably
smaller in cells with reduced ATXN2L or ATXN2 level compared
to controls (Fig. 5D). Similar results were obtained if G3BP was
used as SG marker protein (data not shown). Thus, our findings
demonstrate that ATXN2L is important for SG formation.
ATXN2L Level Influences P-body Formation
We reported earlier that overexpression of ATXN2 influences
the presence of microscopically visible P-bodies in HEK293T cells,
whereas no obvious effect was observed in case ATXN2 levels
were reduced [15]. Consequently, we wanted to analyze the effect
of altered ATXN2L levels on P-body formation as well. First,
HeLa cells were transfected with the expression constructs RSV-
ATXN2L-MYC or pCMV-MYC-ATXN2-Q22 to overexpress
ATXN2L or ATXN2, respectively. Cells were then incubated for
48 h to allow expression of proteins, fixed and treated with an
antibody directed against the MYC-tag to visualize cells overex-
pressing ATXN2L or ATXN2. For visualization of P-bodies an
antibody directed against the component DDX6 was used. As
shown in Fig. 6, cells overexpressing ATXN2L exhibited a diffuse
cytoplasmic localization of DDX6, whereas in non-transfected
cells DDX6 localized to P-bodies. As reported earlier [15], a
comparable reduction in P-body number was observed in cells
overexpressing ATXN2 (Fig. 6). Thus, overexpression of
ATXN2L affects the presence of microscopically visible P-bodies.
We then set out to investigate the effect of a lowered
intracellular ATXN2L level on P-body formation. For this, HeLa
cells were transfected with specific siRNA molecules for ATXN2L
or ATXN2 or with unspecific non-targeting siRNA molecules, and
P-body formation was analyzed by confocal and automated high-
content screening microscopy. Confocal microscopy revealed that
the number of DCP1-positive P-bodies was strongly reduced in
cells with low ATXN2L level compared to control cells treated
with non-targeting molecules (Fig. 7A). Moreover, no obvious
effect on P-body number was detected in cells with reduced
ATXN2 level, which is in consistency with our earlier study using
HEK293T cells [15]. For the quantification of P-bodies using our
automated microscopy approach we again first determined that a
similar number of cells was analyzed, and that no effect occurred
on the nuclear size (Fig. 7B). Interestingly, this approach revealed
that in cells with reduced ATXN2L level the number of DCP1-
and DDX6-positive P-bodies was decreased to 1661% and
3864% compared to the non-targeting control, and the size of P-
bodies was reduced as well (Fig. 7C, D and S5). We also detected a
minor increase in the number and size of microscopically visible P-
bodies in cells with low ATXN2 level. In sum, ATXN2L is a
regulator of P-body formation.
Discussion
In this study, we revealed a functional overlap between
ATXN2L and ATXN2 with regard to RNA metabolism, since
ATXN2L associates with known interaction partners of ATXN2,
the RNA helicase DDX6 and PABP [14,15], and with ATXN2
itself. Moreover, we discovered that ATXN2L is a bona fide
component of SGs in mammalian cells under different stress
conditions. Most importantly, we identified ATXN2L as a
regulator of SGs, since ATXN2L overexpression caused induction
of SGs, whereas a low ATXN2L level reduced the number and
size of SGs. The overexpression or reduction of several proteins
have been reported to affect SG formation or SG composition
[38], possibly at different steps, since the process of SG formation
has been categorized in different stages [22]. The first stage begins
Figure 1. ATXN2L is found in association with PABP, DDX6 and ATXN2. A) Scheme of the domain architecture of ATXN2L and ATXN2
highlighting conserved functional motifs. Lines below indicate antibody epitopes for anti-ATXN2L and anti-ATXN2 (BD Biosciences). B) Cell lysates
were prepared from HEK293T and HeLa cells as described in Materials and Methods. Co-immunoprecipitation experiments were carried out with an
anti-ATXN2L antibody, and precipitated proteins were detected using specific antibodies against PABP, DDX6 or ATXN2 (BD Biosciences). C) HeLa
cells were fixed and ATXN2L or ATXN2 were stained with an anti-ATXN2L antibody or an anti-ATXN2 antibody (Sigma, red). SR-splicing proteins were
stained using an anti-SR antibody (green). Nuclei were visualized by Hoechst staining (blue). Scale bars represent 20 mm.
doi:10.1371/journal.pone.0050134.g001
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with stalled initiation and ribosome runoff marking ribonucleo-
protein complexes as sites where SGs assemble. This stage is
followed by the primary aggregation or SG nucleation step
initiated by RNA-binding proteins with aggregation-prone prop-
erties, such as T-cell-restricted intracellular antigen-1 (TIA-1) and
G3BP [22,37,39], followed by the secondary aggregation step.
Finally, proteins are recruited through protein-protein interactions
[22]. Of note, we observed an association between G3BP and
ATXN2L in HeLa cells that has been originally described in a
high-throughput analysis [36], suggesting that ATXN2L could be
important for the nucleation step as G3BP is. Interestingly, we also
detected an association between ATXN2 and G3BP in this study.
Even so, we observed that ATNX2 overexpression has no effect on
SG induction in HeLa cells under the chosen experimental
settings, whereas a reduced ATXN2 level also affects number and
size of SGs, consistent with our earlier study using HEK293T cells
[15].
Evidence has been provided that posttranslational modifications
of proteins are important in the complex dynamic process of SG
assembly. Many RNA-binding proteins implicated in the primary
nucleation step contain methylatable domains [40,41]. For the
fragile6mental retardation protein (FMRP), the methylation of
its RRG rich domain is important for its function as inducer of
SGs [42]. Remarkably, an arginine methylation site at position
361 in the ATXN2L protein has been identified to be methylated,
whereas this amino acid position is not conserved in the ATXN2
protein [43]. Interestingly, the overexpression of a phosphomi-
metic G3BP mutant failed to assemble SGs, while overexpression
of a nonphosphorylatable G3BP mutant caused SG formation
[37]. Therefore, it can be speculated that differences in
posttranslational modifications between ATXN2L and ATXN2
are accountable for the observed results regarding SG formation, a
task that will be addressed in the future.
On the other hand, we discovered that ATXN2L is a regulator
of P-bodies as well, since ATXN2L overexpression and reduction
decreases the number and size of P-bodies in HeLa cells, whereas
only ATXN2 overexpression had a noticeable effect on P-bodies
as reported earlier [15]. Analogous to the assembly of SGs, P-body
formation is also affected by the overexpression and reduction of
various P-body components [24]. Interestingly, depletion of
DDX6 results in the loss of microscopically visible P-bodies [44].
We speculated in our earlier study that the observed mis-
localization of DDX6 and loss of microscopically visible P-bodies
in cells overexpressing ATXN2 might be based on abnormal
protein interactions attributable to the increase in the interaction
surface, the LSm/LSmAD domain of ATXN2 [15]. Since this
domain is conserved in the ATXN2L protein [10], such a
recruitment mechanism is likely to explain the observed effect as
well. Regarding the effect on P-body number and size observed in
cells with a reduced ATXN2L concentration, it might be of
interest that ATXN2L comprises a sequence in the C-terminal
region that shows homology to the Pat1 protein family, which is
absent in the ATXN2 protein. The Pat1 protein family is
conserved in eukaryotes and two Pat1 proteins, PatL2/Pat1a
and PatL1/Pat1b, exist in humans [45,46]. PatL1/Pat1b is a P-
body component and the expression of PatL1/Pat1b protein
lacking certain domains or its depletion results in loss of
microscopically visible P-bodies, whereas PatL1/Pat1b overex-
pression induces P-body formation [46,47]. Moreover, PatL1/
Pat1b shuttles between the cytoplasm and nucleus, and nuclear
PatL1/Pat1b localizes to splicing speckles, indicating that it is
implicated in RNA-related processes in both cellular compart-
ments [48]. In this light, it is interesting that we observed a co-
localization of ATXN2L and nuclear splicing speckles, suggesting
Figure 2. ATXN2L is a component of SGs under different stress
conditions. A) HeLa cells were subjected to treatment with 0.5 mM
sodium arsenite or heat-shock at 44uC, or B) 0.5 M sorbitol, 2 mM
dithiothreitol (DTT), 2 mM hydrogen peroxide, or 1 mM sodium selenite
for 1 hour, respectively, or left untreated as control. Cells were fixed and
proteins were stained with antibodies directed against ATXN2L (red)
and ATXN2 (BD Biosciences, green). Nuclei were stained with Hoechst
(blue) and scale bars represent 20 mm.
doi:10.1371/journal.pone.0050134.g002
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that ATXN2L may function in splicing processes as well. On the
other hand, localization of splicing factors is regulated by protein
arginine methylation, which also modulates associations between
SR-like proteins and splicing factors [49,50]. Nonetheless, lysine
acetylation is another posttranslational modification that controls
the localization and association of proteins involved in various
cellular processes including amongst others gene transcription,
translation or splicing [51]. A high-resolution mass spectrometry
approach identified ATXN2L as target for lysine acetylation,
while ATXN2 was not detected [52]. Again, such a difference
could be responsible for the observed effects on P-body formation
as well.
Further studies are necessary to dissect and define the function
of ATXN2L in the cellular mRNA metabolism. Moreover, it will
be interesting to further explore the functional interplay between
ATXN2L and ATNX2. As mentioned before, functional studies of
ATXN1L/Boat, the paralog of the disease-causing protein
ATXN1, revealed a suppressive activity in SCA1 disease
pathogenesis [5]. Utilizing a SCA1 Drosophila model, Mizutani
and colleagues showed that an eye defect, caused by mutant
ATXN1, was suppressed by ATXN1L overexpression due to the
association of both proteins [53]. Moreover, evidence was
provided that the activity of mutant ATXN1 causative for the
observed neurotoxic events in a SCA1 knock-in mouse model can
be ameliorated by duplication of ATXN1L modifying incorpora-
tion of mutant ATXN1 into native protein complexes [5].
Consequently, it will be interesting to explore whether gene
dosage compensation or antagonistic behavior between ATXN2L
and ATXN2 might occur in SCA2 transgenic animal models and
whether and how this impacts SCA2 pathogenesis.
Materials and Methods
Plasmids
The plasmids RSV-ATXN2L-MYC and pCMV-MYC-
ATXN2-Q22 were described earlier [11,15]. To generate plasmid
pCMV-MYC-G3BP1, a PCR was carried out using human fetal
brain cDNA library (Clontech) as DNA template and primer pair
G3BP1-s-SalI (59-CGAGGTCGACGGAGAAGCC-
TAGTCCCCTG-39) and G3BP1-as-NotI (59-
CTGCGGCCGCTCACTGCCGTGGCGCAAG-39). After-
wards, the amplified DNA fragment was purified, treated with
SalI and NotI, subcloned into the SalI/NotI sites of the expression
vector pCMV-MYC (Clontech), and validated by sequencing.
Cell Cultivation and Transfection
HEK293T, HeLa and SH-SY5Y cells were cultivated in
DMEM (Dulbecco’s modified Eagle medium, Invitrogen) supple-
mented with 100 units/ml Penicillin/G-Streptomycin (Biochrom)
and 10% fetal bovine serum (FBS, Biochrom) at 37uC and 5%
CO2. Transfections were carried out in 24-well plates using 1–
2 mg RSV-ATXN2L-MYC, pCMV-MYC-ATXN2-Q22, or
Figure 3. ATXN2L behaves as a dynamic SG component like ATXN2. A) HeLa cells were concurrently treated with cycloheximide and 0.5 mM
sodium arsenite for 1 hour. As controls, cells were only treated with sodium arsenite, or cells were left untreated at 37uC. B) Cells were treated with
0.5 mM sodium arsenite for 1 hour and incubated at normal growth conditions for 90 or 180 min to allow recovery. Subsequently, cells were fixed
and stained with antibodies directed against ATXN2L (red) and ATXN2 (BD Biosciences, green). Nuclei were stained with Hoechst (blue). Scale bars
represent 20 mm.
doi:10.1371/journal.pone.0050134.g003
Figure 4. ATXN2L overexpression induces the formation of SGs. A) For co-immunoprecipitation experiments cell lysates were prepared from
HEK293T and HeLa cells as described in Materials and Methods, and experiments were carried out with either anti-ATXN2L or anti-G3BP antibody.
Precipitated proteins were detected with anti-G3BP or anti-ATXN2L. B) Co-immunoprecipitation experiments were carried out with either anti-ATXN2
(Bethyl) or anti-G3BP antibody. Precipitated proteins were detected with anti-G3BP or anti-ATXN2 (Bethyl). C) HeLa cells were transfected with the
expression plasmids RSV-ATXN2L-MYC, pCMV-MYC-ATXN2-Q22 or pCMV-MYC-G3BP1 and incubated for 48 hours to allow expression of the
respective fusion proteins. Afterward, cells were fixed and stained for the MYC-tag (Millipore, green) and eIF4G (red) to monitor induction of SGs.
Nuclei were stained using Hoechst (blue). Scale bars represent 20 mm.
doi:10.1371/journal.pone.0050134.g004
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pCMV-MYC-G3BP1 and 3–6 ml Polyethylenimine (PEI, linear,
MW 25 kDa, 1 mg/ml, pH 7, Polysciences Inc.), respectively.
Then, transfected cells were incubated for 48 hours to allow
transient expression of proteins.
Co-immunoprecipitation
Co-immunoprecipitation experiments were performed as de-
scribed [15]. Briefly, HEK293T, HeLa or SH-SY5Y cells were
washed in PBS, harvested and lysed in lysis buffer [20 mM Tris-
HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton-X100,
2.5% Protease-inhibitor (‘‘complete’’ tablets, Roche), and 25
units/ml benzonase (Merck)] for 30 minutes at 4uC. 300–500 mg
of each cell lysate was incubated with 1.5 ml primary antibody
[rabbit anti-ATXN2L (Bethyl A301-370A), rabbit anti-ATXN2
(Bethyl A301-118A) or mouse anti-G3BP (Abnova)] overnight at
4uC. Then, 15–20 ml IgG conjugated M-280 Dynabeads (Dynal)
were added and samples were incubated for additional 2–3 hours.
Dynabeads were pulled down magnetically and washed three
times with 3% BSA/PBS and 3 times with PBS. Finally, SDS
sample buffer containing 0.1 M DTT was added, samples were
incubated at 95uC for 5 min, and loaded onto a 10% SDS gel.
After separation, proteins were transferred to a PVDF membrane
(Millipore) using a semi-dry blotting system (PeqLab). Subsequent-
ly, membranes were incubated overnight with primary antibodies
as indicated [rabbit anti-ATXN2L (Bethyl, 1:1000), mouse anti-
ATXN2 (BD Biosciences, 1:1000), rabbit anti-ATXN2 (Bethyl,
Figure 5. A reduced ATXN2L level affects the size and number of SGs. HeLa cells were left untreated (mock) or transfected with siRNAs
against ATXN2L or ATXN2 transcripts, or non-targeting control siRNA (siNT). 72 hours post transfection cells were treated with 0.5 mM sodium
arsenite for 1 hour and fixed. A) For the confocal microscopy proteins were stained with an antibody detecting eIF4G. (B-D) For the quantitative
high-content screening microscopy staining occurred with antibodies detecting eIF4G and TIAR. B) Cell number and size of nuclei was analyzed by
quantitative high-content screening microscopy. C, D) Quantification of TIAR- and eIF4G-positive SGs regarding number and size. Results are
expressed as mean 6 SD from one representative experiment, n = 5 replicate wells, *p,0.05; **p,0.01; ***p,0.001, One-way ANOVA with Tukey’s
Multiple Comparison post test.
doi:10.1371/journal.pone.0050134.g005
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1:1000), mouse anti-DDX6 (Abnova, 1:2000), mouse anti-PABP
(Abcam, 1:1000) and mouse anti-G3BP (Abnova, 1:1000)]. Then,
membranes were incubated with secondary antibodies [POD-
conjugated anti-mouse or anti-rabbit, 1:10000 (Sigma)] for 1 hour
and proteins were visualized using Western Lightning ECL
solutions (Perkin Elmer).
RNA Interference Experiments
HeLa cells were seeded in 24-well plates on glass slides in
DMEM supplemented with 10% FBS for 24 hours. Then, 1.2 ml
20 mM siRNA molecules [ATXN2L Stealth Select RNAi Pool
(Invitrogen), ATXN2 On Target Plus Smart Pool, On Target Plus
Non-targeting Pool (Dharmacon)] and 3 ml Lipofectamine RNAi-
MAX transfection reagent (Invitrogen) were mixed, incubated for
10 min and added to the cells. As mock control, untreated cells
were included. 72 hours post transfection cells were exposed to
oxidative stress by treatment with 0.5 mM sodium arsenite for 1
hour or left untreated. Afterward, cells were fixed with 2%
formaldehyde for 10 min and ice-cold methanol for at least
30 min and processed for microscopic analyses as described [15].
For automated microscopy, HeLa cells were seeded in 6-well
plates, treated with siRNA concentrations as described above and
incubated for 72 hours. Then, cells were treated with trypsin,
seeded in 96-well imaging plates (Greiner mClear) for 12–24 hours,
and exposed to arsenite-stress or left untreated. For validation of
knock down, HeLa cells were seeded in 12-well plates and treated
with siRNA concentrations as described above and incubated for
72 hours. Cells were then lysed and proteins were subjected to
SDS-PAGE and Western blotting as described above and detected
using rabbit anti-ATXN2L (Bethyl, 1:1000), mouse anti-ATXN2
(BD Biosciences, 1:1000), mouse anti-G3BP (Abnova, 1:1000) and
mouse anti-GAPDH (Ambion, 1:5000) antibodies. Equal protein
loading was confirmed by Coomassie staining.
Confocal Microscopy
For stress experiments, cells were seeded on glass slides and
either incubated with 0.5 mM sodium arsenite, 0.5 M sorbitol,
2 mM dithiothreitol (DTT), 2 mM hydrogen peroxide (H2O2),
1 mM sodium selenite (Sigma) or exposed to heat stress at 44uC
for 1 hour, while control cells were left untreated. To analyze
the effect of cycloheximide on ATXN2L localization, 10 mg/ml
cycloheximide was added to arsenite or heat-treated cells. For
recovery experiments, medium was removed after the chosen
stress conditions, fresh medium was applied, and cells were
incubated for additional 90–180 min. Cells were then fixed and
proteins were stained with the respective primary antibodies
[rabbit anti-ATXN2L (1:300, Bethyl), mouse anti-ATXN2
(1:200, BD Biosciences), rabbit anti-ATXN2 (1:200, Sigma
HPA020339); mouse anti-DCP1A (1:400, Abnova), rabbit anti-
DDX6 (Novus Biologicals, 200-192), rabbit anti-eIF4G1 (1:200,
Abcam), mouse anti-MYC (1:500, Millipore), mouse anti-PABP
(1:100, Abcam), mouse anti-SR proteins (1:200; Invitrogen) and
mouse anti-TIAR (1:200, BD Biosciences)] in 3% BSA/PBS for
1 hour at room-temperature. After addition of the respective
secondary antibodies [anti-rabbit Alexa Fluor 594 (1:500,
Invitrogen), anti-mouse Alexa Fluor 488 (1:500, Invitrogen)],
nuclei were stained with bisbenzimide (Hoechst, Sigma) and
samples were mounted with Fluoromount-G (Southern Biotech).
Figure 6. P-body formation is influenced by ATXN2L overexpression. HeLa cells were transfected with expression constructs RSV-ATXN2L-
MYC or pCMV-MYC-ATXN2-Q22 to overexpress ATXN2L or ATXN2, respectively. 48 h post transfection, cells were fixed and stained with antibodies
directed against the MYC-tag to visualize ATXN2L or ATXN2 overexpressing cells and an antibody against DDX6. Nuclei were stained with Hoechst.
Images shown are taken from one representative experiment. Scale bars represent 20 mm.
doi:10.1371/journal.pone.0050134.g006
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Cells were analyzed using a confocal microscope (LSM 700,
Zeiss) on an inverted stand (Axiovert 200 M, Zeiss) using
objective Plan-NEOFLUAR 4061.3 oil DIC. Images were
prepared using Zeiss software ZEN version 5.5.
High-content Screening Microscopy
Fixed cells in 96-well imaging plates were stained with the
respective primary antibodies [mouse anti-TIAR (1:200, BD
Biosciences), rabbit anti-eIF4G1 (1:200, Abcam), mouse anti-
DCP1A (1:400, Abnova), rabbit anti-DDX6 (Novus Biologicals,
200-192)] and secondary antibodies [anti-rabbit Alexa Fluor 594
(1:500, Invitrogen), anti-mouse Alexa Fluor 488 (1:500, Invitro-
gen)] in 3% BSA/PBS for 1 hour at room-temperature and nuclei
were stained with DAPI (Sigma). Plates were scanned using a
Thermo Fisher Cellomics ArrayScan VTI. Images of 5126512
pixels were acquired with a 206objective and analyzed using the
Cellomics software package (Colocalization V.4 Bioapplication).
Cell nuclei were identified by DAPI staining and according to the
object identification parameters size: 100–1200 mm2, ratio of
perimeter squared to 4p area: 1–2, length-to-width ratio: 1–2,
average intensity: 50–1000, total intensity: 36104226107. SGs
and P-bodies were identified within a circular region extending the
nucleus by maximally 20 mm. The object identification parameters
for SGs and P-bodies were: 1.5–20 mm2, ratio of perimeter
squared to 4p area: 1–1.8, length-to-width ratio: 1–1.8, average
intensity: 100–1500, total intensity: 56103–56104.
Figure 7. ATXN2L reduction affects P-body formation. HeLa cells were left untreated (mock) or transfected with siRNAs against ATXN2L or
ATXN2 transcripts, or non-targeting control siRNAs. The cells were fixed 72 hours post transfection, and analyzed A) by confocal microscopy or B–D)
by quantitative high-content screening microscopy. In A) cells were stained with an antibody detecting DCP1. In B–D) cells were stained with
antibodies detecting DCP1 and DDX6. B) Cell numbers and size of nuclei of analyzed cells. C, D) Quantification of DCP1- and DDX6-positive P-bodies
regarding number and size. Results are expressed as mean 6 SD from one representative experiment, n = 5 replicate wells, *p,0.05; **p,0.01;
***p,0.001, One-way ANOVA with Tukey’s Multiple Comparison post test.
doi:10.1371/journal.pone.0050134.g007
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Supporting Information
Figure S1 ATXN2L interacts and co-localizes with
different SG marker proteins. A) Cell lysates were prepared
from SH-SY5Y cells and co-immunoprecipitation experiments
were carried out with an anti-ATXN2L antibody. Precipitated
proteins were detected using specific antibodies against PABP,
DDX6 or ATXN2 (BD Biosciences). B, C) HeLa cells were
treated with 0.5 mM sodium arsenite or heat-shocked at 44uC for
1 hour with control cells left untreated at 37uC. Afterward, cells
were fixed and stained with the corresponding antibodies to
visualize ATXN2L (red) and B) TIAR (green) or C) PABP (green),
respectively. Hoechst staining (blue) was used for the detection of
nuclei. Scale bars correspond to 20 mm.
(TIF)
Figure S2 ATXN2L behaves as a dynamic SG compo-
nent under heat stress. A) HeLa cells were heat-shocked in the
presence of cycloheximide at 44uC for 1 hour. Heat-shocked cells
or cells left untreated at 37uC served as controls. B) HeLa cells
were heat-shocked at 44uC for 1 hour and incubated at normal
growth conditions for 90 or 180 min to allow recovery.
Subsequently, cells were fixed and stained with antibodies directed
against ATXN2L (red) and ATXN2 (BD Biosciences, green).
Nuclei were stained with Hoechst (blue). Scale bars correspond to
20 mm.
(TIF)
Figure S3 Efficiency and specificity of ATXN2L and
ATXN2 knock-down. A) HeLa cells were left untreated (mock)
or transfected with non-targeting (siNT), or ATXN2L- or
ATXN2-specific siRNAs, lysed 72 hours post transfection and
subjected to SDS-PAGE. Protein level of ATXN2L, ATXN2 (BD
Biosciences), G3BP and GAPDH was analyzed using the
corresponding antibodies. To show loading of equal amounts of
protein, gel was stained using Coomassie blue. B) HeLa cells were
transfected with non-targeting (siNT), or ATXN2L- or ATXN2-
specific siRNA molecules, fixed 72 hours post transfection and
stained with antibodies directed against ATXN2L (red) and
ATXN2 (BD Biosciences, green).
(TIF)
Figure S4 Quantification of TIAR- and eIF4G-positive
SGs. HeLa cells were left untreated (mock) or transfected with
non-targeting (siNT), or ATXN2L- or ATXN2-specific siRNA
molecules. 72 h post transfection cells were treated with 0.5 mM
sodium arsenite for 1 hour to induce SG formation, fixed, and
stained with TIAR- and eIF4G-specific antibodies. Cell nuclei
were stained with DAPI. Representative view fields of the
automated image analysis are shown. Green encircled nuclei were
selected; red encircled nuclei were rejected by the object
identification algorithm. Outer cell borders (blue lines) were
calculated by extending the nuclear region. TIAR-positive (yellow)
and eIF4G-positive (magenta) SGs were quantified within whole
cells.
(TIF)
Figure S5 Quantification of DCP1- and DDX6-positive
P-bodies. HeLa cells were left untreated (mock) or transfected
with non-targeting (siNT), ATXN2L- or ATXN2-specific siRNA
molecules. 72 h post transfection cells were fixed and stained with
DCP1- and DDX6-specific antibodies. Cell nuclei were stained
with DAPI. Representative view fields of the automated image
analysis are shown. Green encircled nuclei were selected; red
encircled nuclei were rejected by the object identification
algorithm. Outer cell borders (blue lines) were calculated by
extending the nuclear region. DCP1-positive (yellow) and DDX6-
positive (magenta) P-bodies were quantified within whole cells.
(TIF)
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